Losartan Potassium

Product NDC: 70934-616
Requested package NDC: 70934-616-30
11-digit product format: 709340616
Labeler code: 70934
Product ID: 70934-616_ab6dbf2a-3a63-6dea-e053-2995a90a988a
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Losartan Potassium
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Denton Pharma, Inc. dba Northwind Pharmaceuticals
Application: ANDA203835
Marketing category: ANDA
Marketing start: 2020-06-11
Marketing end: 0000-00-00
Substance: LOSARTAN POTASSIUM
Active strength: 25 mg/1
Pharmacologic classes: Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	70934-616	70934-616-30	D	Discontinued by firm		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 15 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Code, Status table
Captured / source date	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2022-08-30 03:57 UTC · source 2022-08-29	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A203835-001	LOSARTAN POTASSIUM	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2015-08-12
A203835-002	LOSARTAN POTASSIUM	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	AB	2015-08-12
A203835-003	LOSARTAN POTASSIUM	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	AB	2015-08-12

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A203835-001	AB
A203835-002	AB
A203835-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A203835-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2015-08-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203835-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	AB	2015-08-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203835-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	AB	2015-08-12	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A203835-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2015-08-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203835-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	AB	2015-08-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203835-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	AB	2015-08-12	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203835-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2015-08-12	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203835-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	AB	2015-08-12	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203835-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	AB	2015-08-12	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A203835-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2015-08-12	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203835-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	AB	2015-08-12	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203835-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	AB	2015-08-12	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203835-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2015-08-12	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203835-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	AB	2015-08-12	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203835-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	AB	2015-08-12	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203835-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2015-08-12	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203835-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	AB	2015-08-12	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203835-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	AB	2015-08-12	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203835-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2015-08-12	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203835-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	AB	2015-08-12	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203835-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	AB	2015-08-12	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203835-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2015-08-12	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203835-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	AB	2015-08-12	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203835-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	AB	2015-08-12	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203835-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2015-08-12	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203835-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	AB	2015-08-12	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203835-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	AB	2015-08-12	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203835-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2015-08-12	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203835-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	AB	2015-08-12	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203835-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	AB	2015-08-12	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A203835-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2015-08-12	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A203835-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	AB	2015-08-12	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A203835-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	AB	2015-08-12	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A203835-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2015-08-12	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A203835-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	AB	2015-08-12	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A203835-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	AB	2015-08-12	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A203835-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2015-08-12	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A203835-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	AB	2015-08-12	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A203835-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	AB	2015-08-12	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A203835-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2015-08-12	`1e350fbaab3a…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A203835-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203835-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203835-003	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A203835-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203835-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203835-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203835-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203835-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203835-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A203835-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203835-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203835-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203835-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203835-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203835-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203835-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203835-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203835-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203835-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203835-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203835-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203835-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203835-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203835-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203835-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203835-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203835-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203835-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203835-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203835-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A203835-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A203835-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A203835-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A203835-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A203835-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A203835-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A203835-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A203835-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A203835-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A203835-001	AB	1	`1e350fbaab3a…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
70934-616-30	2023-01-30	These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets, for oral use Initial U.S. Approval: 1995
70934-616-90	2023-01-30	These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets, for oral use Initial U.S. Approval: 1995
70934-616-30	2022-01-28	These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets, for oral use Initial U.S. Approval: 1995
70934-616-90	2022-01-28	These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets, for oral use Initial U.S. Approval: 1995

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
70934-616-30	EA - Each	70934-616	f062cf50-9e4f-4700-bd60-ef5b6c8e7e42	1	2022-12-07
70934-616-90	EA - Each	70934-616	59fc0cd5-c956-482e-aec1-58b0776fd225	1	2022-12-07

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 3 · 46 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Losartan Potassium	LOSARTAN POTASSIUM	Redpharm Drug	5833c02c-9957-a069-e063-6294a90ad3e4	2026-08-04	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203835 application number: ANDA203835
Losartan Potassium	LOSARTAN POTASSIUM	REMEDYREPACK INC.	6f39f7f9-edac-45ca-9ee2-c2ecad0915ab	2026-07-10	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203835 application number: ANDA203835
Losartan Potassium	LOSARTAN POTASSIUM	PD-Rx Pharmaceuticals, Inc.	1843ee4b-1afc-4992-993a-4b0e03e785fc	2026-07-07	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203835 application number: ANDA203835
Losartan Potassium	LOSARTAN POTASSIUM	PD-Rx Pharmaceuticals, Inc.	9b3ddaa2-a835-736a-e053-2995a90aff08	2026-07-07	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203835 application number: ANDA203835
Losartan Potassium	LOSARTAN POTASSIUM	REMEDYREPACK INC.	45c01cc9-c7d1-4bb6-a105-354fc936ec63	2026-06-10	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203835 application number: ANDA203835
Losartan Potassium	LOSARTAN POTASSIUM	Coupler LLC	53e82c07-fe4c-78db-e063-6394a90a8087	2026-06-10	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203835 application number: ANDA203835
Losartan Potassium	LOSARTAN POTASSIUM	St. Mary's Medical Park Pharmacy	aaf943ff-d6af-8ce2-e053-2995a90a7b76	2026-06-07	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203835 application number: ANDA203835
Losartan Potassium	LOSARTAN POTASSIUM	Bryant Ranch Prepack	0f3a6984-e601-4a74-9910-49ee5e352d6b	2026-06-04	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203835 application number: ANDA203835
Losartan Potassium	LOSARTAN POTASSIUM	Preferred Pharmaceuticals, Inc.	fe1df76d-4925-444d-8e30-9dd07f205fb7	2026-05-29	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203835 application number: ANDA203835
Losartan Potassium	LOSARTAN POTASSIUM	PD-Rx Pharmaceuticals, Inc.	abb56236-f2fe-45b5-93ac-35fd661f8992	2026-05-21	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203835 application number: ANDA203835
Losartan Potassium	LOSARTAN POTASSIUM	A-S Medication Solutions	23117ad8-39ad-44f2-b7d2-2dbc8edc9734	2026-04-02	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203835 application number: ANDA203835
Losartan Potassium	LOSARTAN POTASSIUM	A-S Medication Solutions	d7b61f05-871d-4ffd-ab9b-9a3e60fd34c4	2026-04-02	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203835 application number: ANDA203835
Losartan Potassium	LOSARTAN POTASSIUM	NuCare Pharmaceuticals,Inc.	ba76eb91-bea6-4e37-e053-2a95a90a065a	2026-02-19	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203835 application number: ANDA203835
Losartan Potassium	LOSARTAN POTASSIUM	A-S Medication Solutions	3ee3240f-78a1-4fd2-a779-c22693711721	2026-02-14	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203835 application number: ANDA203835
Losartan Potassium	LOSARTAN POTASSIUM	A-S Medication Solutions	f29cc61a-afba-4ecb-8043-5f103872f1ae	2026-02-14	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203835 application number: ANDA203835
Losartan Potassium	LOSARTAN POTASSIUM	A-S Medication Solutions	2c810cde-fa40-4772-806e-c31809e6bbfb	2026-02-11	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203835 application number: ANDA203835
Losartan Potassium	LOSARTAN POTASSIUM	Northwind Health Company, LLC	d9df33c8-4ea7-5d1c-e053-2a95a90aecf7	2026-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203835 application number: ANDA203835
Losartan Potassium	LOSARTAN POTASSIUM	QPharma, Inc.	0c9f3e8c-eafb-4be4-aca5-1d5aa3d7d738	2025-12-19	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203835 application number: ANDA203835
Losartan Potassium	LOSARTAN POTASSIUM	QPharma, Inc.	c80b36c2-fa22-e7a9-e053-2a95a90ae21e	2025-12-19	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203835 application number: ANDA203835
Losartan Potassium	LOSARTAN POTASSIUM	QPharma, Inc.	c80b3a28-ef15-5902-e053-2995a90a06d7	2025-12-19	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203835 application number: ANDA203835

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
3ST302B24A	LOSARTAN POTASSIUM	124750-99-8	LOSARTAN POTASSIUM

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
70934-616-30	70934061630	30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70934-616-30)	2020-06-11	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Losartan Potassium	Denton Pharma, Inc. dba Northwind Pharmaceuticals	2023-01-10	HUMAN PRESCRIPTION DRUG LABEL	2